Comment on Hogas et al. Salt, Not Always a Cardiovascular Enemy? A Mini-Review and Modern Perspective. Medicina 2022, 58, 1175
Conflicts of Interest
References
- Hogas, M.; Statescu, C.; Padurariu, M.; Ciobica, A.; Bilha, S.C.; Haisan, A.; Timofte, D.; Hogas, S. Salt, Not Always a Cardiovascular Enemy? A Mini-Review and Modern Perspective. Medicina 2022, 58, 1175. [Google Scholar] [CrossRef] [PubMed]
- Campbell, N.R.C.; Whelton, P.K.; Orias, M.; Wainford, R.D.; Cappuccio, F.P.; Ide, N.; Neal, B.; Cohn, J.; Cobb, L.K.; Webster, J.; et al. 2022 World Hypertension League, Resolve To Save Lives and International Society of Hypertension dietary sodium (salt) global call to action. J. Hum. Hypertens. 2022, 1–10. [Google Scholar] [CrossRef] [PubMed]
- Ma, Y.; He, F.J.; Sun, Q.; Yuan, C.; Kieneker, L.M.; Curhan, G.C.; MacGregor, G.A.; Bakker, S.J.L.; Campbell, N.R.C.; Wang, M.; et al. 24-h urinary sodium and potassium excretion and cardiovascular risk. N. Engl. J. Med. 2022, 386, 252–263. [Google Scholar] [CrossRef]
- Cappuccio, F.P.; Campbell, N.R.; He, F.J.; Jacobson, M.F.; MacGregor, G.A.; Antman, E.; Appel, L.J.; Arcand, J.; Blanco-Metzler, A.; Cook, N.R.; et al. Sodium and health: Old myths, and a controversy based on denial. Curr. Nutr. Rep. 2022, 11, 172–184. [Google Scholar] [CrossRef] [PubMed]
- Campbell, N.R.C.; He, F.J.; Cappuccio, F.P.; MacGregor, G.A. Dietary sodium ‘controversy’—Issues and potential solutions. Curr. Nutr. Rep. 2021, 10, 188–199. [Google Scholar] [CrossRef] [PubMed]
- Campbell, N.R.C.; He, F.J.; McLean, R.M.; Cappuccio, F.P.; Woodward, G.A.M. Dietary sodium and cardiovascular disease in China: Addressing the authors’ response, statements and claims. J. Hypertens. 2022, 40, 1831–1836. [Google Scholar] [CrossRef] [PubMed]
- Cobb, L.K.; Anderson, C.A.; Elliott, P.; Hu, F.B.; Liu, K.; Neaton, J.D.; Whelton, P.K.; Woodword, M.; Appel, L.J.; American Heart Association Council on Lifestyle and Metabolic Health. Methodological issues in cohort studies that relate sodium intake to cardiovascular disease outcomes: A science advisory from the American Heart Association. Circulation 2014, 129, 1173–1186. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Appel, L.J.; Foti, K. Extreme variability in urinary sodium excretion: Time to stop use of spot urines to predict clinical outcomes. Hypertension 2021, 78, 1637–1639. [Google Scholar] [CrossRef] [PubMed]
- Re, F.; Hammami, I.; Littlejohns, T.J.; Arnold, M.; Lewington, S.; Clarke, R.J.; Carter, J.L. Effects of within-person variability in spot urinary sodium measurements on associations with blood pressure and cardiovascular disease. Hypertension 2021, 78, 1628–1636. [Google Scholar] [CrossRef] [PubMed]
- O’Donnell, M.; Mente, A.; Alderman, M.H.; Brady, A.J.B.; Diaz, R.; Gupta, R.; López-Jaramillo, P.; Luft, F.C.; Lüscher, T.F.; Mancia, G.; et al. Salt and cardiovascular disease: Insufficient evidence to recommend low sodium intake. Eur. Heart J. 2020, 41, 3363–3373. [Google Scholar] [CrossRef] [PubMed]
- Naser, A.M.; He, F.J.; Rahman, M.; Campbell, N.R.C. Spot urine formulas to estimate 24-hour urinary sodium excretion alter the dietary sodium and blood pressure relationship. Hypertension 2021, 77, 2127–2137. [Google Scholar] [CrossRef] [PubMed]
- He, F.J.; Ma, Y.; Campbell, N.R.C.; MacGregor, G.A.; Cogswell, M.E.; Cook, N.R. Formulas to estimate dietary sodium intake from spot urine alter sodium-mortality relationship. Hypertension 2019, 74, 572–580. [Google Scholar] [CrossRef] [PubMed]
- Campbell, N.R.C.; He, F.J.; Tan, M.; Cappuccio, F.P.; Neal, B.; Woodward, M.; Cogswell, M.E.; McLean, R.; Arcand, J.; Macregor, G.; et al. The International Consortium for Quality Research on Dietary Sodium/Salt (TRUE) position statement on the use of 24-hour, spot, and short duration (<24 h) timed urine collections to assess dietary sodium intake. J. Clin. Hypertens. 2019, 21, 700–709. [Google Scholar]
- Taylor, R.S.; Ashton, K.E.; Moxham, T.; Hooper, L.; Ebrahim, S. Reduced dietary salt for the prevention of cardiovascular disease: A meta-analysis of randomized controlled trials (cochrane review). Am. J. Hypertens. 2011, 24, 843–853. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ezekowitz, J.A.; Colin-Ramirez, E.; Ross, H.; Escobedo, J.; Macdonald, P.; Troughton, R.; Saldarriaga, C.; Alemayehu, W.; McAlister, F.A.; Arcand, J.; et al. Reduction of dietary sodium to less than 100 mmol in heart failure (SODIUM-HF): An international, open-label, randomised, controlled trial. Lancet 2022, 399, 1391–1400. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Campbell, N.R.C.; Cappuccio, F.P.; McLean, R.M.; He, F.J.; MacGregor, G.A. Comment on Hogas et al. Salt, Not Always a Cardiovascular Enemy? A Mini-Review and Modern Perspective. Medicina 2022, 58, 1175. Medicina 2023, 59, 51. https://doi.org/10.3390/medicina59010051
Campbell NRC, Cappuccio FP, McLean RM, He FJ, MacGregor GA. Comment on Hogas et al. Salt, Not Always a Cardiovascular Enemy? A Mini-Review and Modern Perspective. Medicina 2022, 58, 1175. Medicina. 2023; 59(1):51. https://doi.org/10.3390/medicina59010051
Chicago/Turabian StyleCampbell, Norm R. C., Francesco P. Cappuccio, Rachael M. McLean, Feng J. He, and Graham A. MacGregor. 2023. "Comment on Hogas et al. Salt, Not Always a Cardiovascular Enemy? A Mini-Review and Modern Perspective. Medicina 2022, 58, 1175" Medicina 59, no. 1: 51. https://doi.org/10.3390/medicina59010051